![Christopher Lai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Lai
Algemeen Directeur bij
METIS TECHBIO CO., LTD.
Vermogen: 289 M $ op 30-06-2026
Profiel
Dr. Christopher Lai is a Chairman & Chief Executive Officer at Metis TechBio Co., Ltd., a General Manager & Executive Director at Metis Pharmaceuticals and a Chief Executive Officer at METiS Therapeutics, Inc. He is on the Board of Directors at Metis Pharmaceuticals.
Dr. Lai was previously employed as a Chief Technology Officer by AquaFresco, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-06-2026 | 111.166.572 ( 10,26% ) | 218 M $ | 30-06-2026 | |
METIS TECHBIO CO., LTD. 36,55% | 13-05-2026 | 36.400.278 ( 36,55% ) | 71 M $ | 30-06-2026 |
Actieve functies van Christopher Lai
| Bedrijven | Functie | Begin |
|---|---|---|
| METIS TECHBIO CO., LTD. | Algemeen Directeur | 10-01-2020 |
METiS Therapeutics, Inc.
 METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Algemeen Directeur | - |
Eerdere bekende functies van Christopher Lai
| Bedrijven | Functie | Einde |
|---|---|---|
AquaFresco, Inc.
 AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
AquaFresco, Inc.
AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Producer Manufacturing |
METiS Therapeutics, Inc.
METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Health Technology |
Hangzhou Jitai Pharmaceutical Technology Co. Ltd.
 Hangzhou Jitai Pharmaceutical Technology Co. Ltd. Chemicals: Major DiversifiedProcess Industries Operates as an investment holding company whose subsidiaries provides AI based nanomaterials delivery and application services | Process Industries |
